Harpal Sandhu, MD
Retina Specialist · Portland, ORNPI 1811204894
Payments from drug & device makers
What this record shows
9 manufacturers reported payments, led by Boston Scientific at 59.7% of the total. Reporting peaked in 2020 at $1,499 and has fallen 82.1% since, to $268 in 2025.
Across 14 payments — averaging $185.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Regeneron$317
- Genentech USA, Inc.$267
- Eyepoint US, Inc.$119
- Regeneron Healthcare Solutions, Inc.$119
- Novartis$110
- plus $115 from 3 others
What the payments were for
- Grants$1,40054%
- Food & beverage$1,19846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $1,550 |
| Regeneron | 3 | $317 |
| Genentech USA, Inc. | 2 | $267 |
| Eyepoint US, Inc. | 1 | $119 |
| Regeneron Healthcare Solutions, Inc. | 1 | $119 |
| Novartis | 2 | $110 |
| Alimera Sciences, Inc. | 1 | $85 |
| Alcon | 1 | $17 |
| Biosense Webster, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$1,400
- VABYSMO$267
- EYLEA$241
- EYLEA HD$240
- GENERAL - THERAPIES$150
- YUTIQ$119
How this compares
$2,598 in reported general payments places this provider in the 65th percentile of 36 retina specialist providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 139 | $5,171 |
| Difluprednate | 26 | $2,839 |
| ValacyclovirValacyclovir Hcl | 14 | $1,863 |
| Ketorolac Tromethamine | 44 | $1,538 |
| Mycophenolate Mofetil | 11 | $650 |
| Latanoprost | 35 | $621 |
| Prednisone | 36 | $480 |
| MoxifloxacinMoxifloxacin Hcl | 22 | $464 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 23 | $303 |
| Diclofenac Sodium | 16 | $233 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $154 |
| Brimonidine Tartrate | 18 | $125 |
| Timolol Maleate | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Portland
- Brian Chan KaiPortland$155K
- Brandon LujanPortland$33K
- Andreas LauerPortland$17K
- Sirichai PasadhikaPortland$6K
- David WilsonPortland$5K
- Aristomenis ThanosPortland$3K
- Michael LeePortland$3K
- Paul TlucekPortland$2K
- Kavita BhavsarPortland$2K
- Apurva PatelPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.